Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study

Show other versions (1)

In this prospective phase II clinical trial, multiple myeloma (MM) patients were randomized to receive a second (tandem) autologous stem cell transplantation (ASCT) based on whether they achieved a partial response or worse (≤PR) following initial ASCT (ASCT1). Patients who achieved a very good part...

Full description

Bibliographic Details
Main Authors: Michael Byrne, Donya Salmasinia, Helen Leather, Christopher R. Cogle, Amy Davis, Jack W. Hsu, Laura Wiggins, Myron N. Chang, Qi An, John R. Wingard, Jan S. Moreb
Format: Article
Language:English
Published: SAGE Publishing 2014-01-01
Series:Clinical Medicine Insights: Oncology
Online Access:https://doi.org/10.4137/CMO.S16835

Similar Items

Similar Items